![](https://growcola.com/wp-content/uploads/2023/05/ap23139717518933-74040faba76ad402ab2743cc2914e79d3c77f290-s1600-c85-1024x767.jpg)
The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven effective in reversing overdoses caused by fentanyl and other opioids.
The spray, known as Opvee, is the “the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older,” the FDA said in the announcement, adding that it is also the “first FDA approval of nalmefene hydrochloride nasal spray for health care and community use.”
The approval is yet another step by policymakers in
Read full article on High Times